This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Church & Dwight Sales to Gain on International Unit & More
by Zacks Equity Research
Church & Dwight's (CHD) top line has been impressive for a while, gaining from strong Consumer International unit, buyouts and innovation.
UN or CL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UN vs. CL: Which Stock Is the Better Value Option?
Kimberly-Clark (KMB) Stock Up on Q1 Earnings & Sales Beat
by Zacks Equity Research
Kimberly-Clark's (KMB) top and bottom lines beat the Zacks Consensus Estimate in Q1. However, cost woes lingered.
Estee Lauder (EL) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Estee Lauder (EL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
UN or CL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UN vs. CL: Which Stock Is the Better Value Option?
Moving Average Crossover Alert: Unilever
by Zacks Equity Research
Unilever N.V. (UN) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
P&G Witnesses Balanced Risk-Reward: Stock Up 31.2% in a Year
by Zacks Equity Research
P&G (PG) gains from initiatives to improve product, packaging & marketing efforts, and productivity & cost-saving plans. However, strained margins and currency headwinds remain concerns.
Church & Dwight (CHD) Up 20% in 6 Months: Will Momentum Stay?
by Zacks Equity Research
Church & Dwight (CHD) flaunts an impressive sales trend, owing to the strong Consumer International unit, focus on acquisitions and brand enhancement initiatives. However, margin woes remain.
Zacks.com featured expert Kevin Matras highlights: Unilever, Rent-A-Center, Abercrombie & Fitch, Taro Pharmaceutical and PCTEL
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Unilever, Rent-A-Center, Abercrombie & Fitch, Taro Pharmaceutical and PCTEL
Buy These 5 Low-Beta Stocks to Survive the Volatility Scare
by Zacks Equity Research
Low-beta stocks could be profitable if we take some other parameters into account.